Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
TD Cowen analyst Joseph Thome initiates coverage on Rapport Therapeutics (NASDAQ:RAPP) with a Buy rating.
Jefferies analyst Andrew Tsai initiates coverage on Rapport Therapeutics (NASDAQ:RAPP) with a Buy rating and announces Price...
Stifel analyst Paul Matteis initiates coverage on Rapport Therapeutics (NASDAQ:RAPP) with a Buy rating and announces Price T...
